13
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Complement Components and Fibrinogen: Correlations and Association with Previous Myocardial Infarction

      research-article

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Serum complement levels have been found to be predictive of myocardial infarction up to 4 years before the acute event. To assess whether they are a marker of a hypercoagulable state, the serum or plasma levels of C3, C4, C3a, C4a, Cl inactivator, antithrombin III, protein S, protein C, fibrinogen and tissue plasminogen activator were measured in 31 patients with previous myocardial infarction and 33 controls (all males, 40-60 years old). C3, C4 and fibrinogen (which share the common characteristic of being acute phase proteins) were correlated and were associated with previous myocardial infarction, although this association persisted only for C4 in multivariate analysis. None of the coagulative variables directly involved in the complement system differed significantly in the two groups.

          Related collections

          Author and article information

          Journal
          CRD
          Cardiology
          10.1159/issn.0008-6312
          Cardiology
          S. Karger AG
          0008-6312
          1421-9751
          1995
          1995
          19 November 2008
          : 86
          : 3
          : 232-237
          Affiliations
          aIstituto di Patologia Speciale Medica e Metodologia Clinica, Università di Bologna, bServizio di Angiologia e Malattie della Coagulazione, dLaboratorio Centralizzato e eServizio di Immunoematologia e Trasfusionale, S. Orsola Hospital, e cLaboratorio Centralizzato, M. Malpighi Hospital, Bologna, Italia
          Article
          176879 Cardiology 1995;86:232–237
          10.1159/000176879
          7614496
          3c293ff7-cc51-4ac5-bbcf-8ba6f85221be
          © 1995 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          : 19 August 1994
          : 30 November 1994
          Page count
          Pages: 6
          Categories
          Coronary Care

          General medicine,Neurology,Cardiovascular Medicine,Internal medicine,Nephrology
          Cl inactivator,Fibrinogen,Protein C,Protein S,Antithrombin III,Tissue plasminogen activator,Myocardial infarction,Complement 3,Complement 4,Complement activation

          Comments

          Comment on this article